Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study.
Clinical trial NCT06646445 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06646445
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.